Precision Short Long Term Debt vs Total Assets Analysis

DTIL Stock  USD 7.11  0.25  3.64%   
Precision BioSciences financial indicator trend analysis is much more than just breaking down Precision BioSciences prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Precision BioSciences is a good investment. Please check the relationship between Precision BioSciences Short Long Term Debt and its Total Assets accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Precision BioSciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
For more information on how to buy Precision Stock please use our How to buy in Precision Stock guide.

Short Long Term Debt vs Total Assets

Short Long Term Debt vs Total Assets Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Precision BioSciences Short Long Term Debt account and Total Assets. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between Precision BioSciences' Short Long Term Debt and Total Assets is -0.24. Overlapping area represents the amount of variation of Short Long Term Debt that can explain the historical movement of Total Assets in the same time period over historical financial statements of Precision BioSciences, assuming nothing else is changed. The correlation between historical values of Precision BioSciences' Short Long Term Debt and Total Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Short Long Term Debt of Precision BioSciences are associated (or correlated) with its Total Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Assets has no effect on the direction of Short Long Term Debt i.e., Precision BioSciences' Short Long Term Debt and Total Assets go up and down completely randomly.

Correlation Coefficient

-0.24
Relationship DirectionNegative 
Relationship StrengthInsignificant

Short Long Term Debt

The total of a company's short-term and long-term borrowings.

Total Assets

Total assets refers to the total amount of Precision BioSciences assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Precision BioSciences books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.
Most indicators from Precision BioSciences' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Precision BioSciences current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Precision BioSciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
For more information on how to buy Precision Stock please use our How to buy in Precision Stock guide.At this time, Precision BioSciences' Sales General And Administrative To Revenue is quite stable compared to the past year. Enterprise Value Over EBITDA is expected to rise to 1.42 this year, although the value of Selling General Administrative will most likely fall to about 29 M.
 2021 2022 2023 2024 (projected)
Gross Profit115.5M16.1M40.5M33.4M
Total Revenue115.5M25.1M48.7M35.8M

Precision BioSciences fundamental ratios Correlations

0.280.810.9-0.550.93-0.760.030.950.610.950.28-0.680.830.610.980.780.780.80.79-0.940.90.670.040.650.88
0.280.560.020.020.13-0.53-0.290.280.490.280.340.150.460.670.30.070.020.020.45-0.040.240.490.360.270.49
0.810.560.56-0.540.69-0.940.040.680.670.680.59-0.690.920.820.760.570.730.660.88-0.630.810.70.150.60.97
0.90.020.56-0.570.94-0.470.060.820.530.820.06-0.620.580.220.860.860.80.840.56-0.930.850.45-0.310.540.67
-0.550.02-0.54-0.57-0.640.6-0.11-0.3-0.36-0.3-0.670.7-0.65-0.05-0.4-0.53-0.9-0.9-0.50.39-0.8-0.040.6-0.43-0.6
0.930.130.690.94-0.64-0.680.280.830.440.830.34-0.690.770.360.90.760.850.830.57-0.880.870.38-0.250.580.82
-0.76-0.53-0.94-0.470.6-0.68-0.22-0.63-0.5-0.63-0.750.69-0.99-0.78-0.71-0.44-0.69-0.61-0.750.53-0.77-0.52-0.17-0.65-0.96
0.03-0.290.040.06-0.110.28-0.22-0.02-0.53-0.020.39-0.320.25-0.090.05-0.130.19-0.02-0.36-0.04-0.05-0.47-0.150.070.19
0.950.280.680.82-0.30.83-0.63-0.020.481.00.1-0.470.690.630.990.630.570.610.71-0.930.720.680.240.470.74
0.610.490.670.53-0.360.44-0.5-0.530.480.480.02-0.460.480.520.520.760.490.560.79-0.530.740.830.050.680.61
0.950.280.680.82-0.30.83-0.63-0.021.00.480.1-0.470.690.630.990.630.570.610.71-0.930.720.680.240.470.74
0.280.340.590.06-0.670.34-0.750.390.10.020.1-0.430.730.340.20.00.540.430.330.010.42-0.1-0.170.260.6
-0.680.15-0.69-0.620.7-0.690.69-0.32-0.47-0.46-0.47-0.43-0.72-0.36-0.57-0.66-0.83-0.76-0.60.65-0.79-0.380.18-0.65-0.75
0.830.460.920.58-0.650.77-0.990.250.690.480.690.73-0.720.730.780.50.750.690.74-0.610.820.490.10.660.96
0.610.670.820.22-0.050.36-0.78-0.090.630.520.630.34-0.360.730.640.250.240.20.77-0.460.450.80.680.460.74
0.980.30.760.86-0.40.9-0.710.050.990.520.990.2-0.570.780.640.690.670.680.74-0.940.80.660.160.560.82
0.780.070.570.86-0.530.76-0.44-0.130.630.760.630.0-0.660.50.250.690.740.790.63-0.790.850.59-0.260.770.63
0.780.020.730.8-0.90.85-0.690.190.570.490.570.54-0.830.750.240.670.740.970.65-0.690.910.29-0.480.530.79
0.80.020.660.84-0.90.83-0.61-0.020.610.560.610.43-0.760.690.20.680.790.970.69-0.710.940.35-0.480.540.72
0.790.450.880.56-0.50.57-0.75-0.360.710.790.710.33-0.60.740.770.740.630.650.69-0.670.80.850.220.530.79
-0.94-0.04-0.63-0.930.39-0.880.53-0.04-0.93-0.53-0.930.010.65-0.61-0.46-0.94-0.79-0.69-0.71-0.67-0.78-0.64-0.03-0.53-0.71
0.90.240.810.85-0.80.87-0.77-0.050.720.740.720.42-0.790.820.450.80.850.910.940.8-0.780.57-0.230.740.86
0.670.490.70.45-0.040.38-0.52-0.470.680.830.68-0.1-0.380.490.80.660.590.290.350.85-0.640.570.510.530.6
0.040.360.15-0.310.6-0.25-0.17-0.150.240.050.24-0.170.180.10.680.16-0.26-0.48-0.480.22-0.03-0.230.510.060.06
0.650.270.60.54-0.430.58-0.650.070.470.680.470.26-0.650.660.460.560.770.530.540.53-0.530.740.530.060.69
0.880.490.970.67-0.60.82-0.960.190.740.610.740.6-0.750.960.740.820.630.790.720.79-0.710.860.60.060.69
Click cells to compare fundamentals

Precision BioSciences Account Relationship Matchups

Precision BioSciences fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets235.2M150.2M211.5M238.2M159.8M179.4M
Other Current Liab1.6M7.9M9.9M11.1M11.4M6.7M
Total Current Liabilities26.9M42.8M36.0M59.7M50.0M34.0M
Total Stockholder Equity138.3M44.4M91.2M60.4M18.9M17.9M
Other Liab70.0M54.3M77.1M93.1M83.8M64.4M
Net Tangible Assets136.9M43.1M89.1M59.1M67.9M52.7M
Retained Earnings(177.1M)(286.1M)(316.7M)(428.3M)(489.6M)(465.1M)
Accounts Payable2.0M792K1.1M653K3.0M1.8M
Cash180.9M89.8M143.7M189.6M116.7M134.8M
Other Assets558K8.1M11.5M9.8M1.00.95
Cash And Short Term Investments180.9M89.8M143.7M189.6M116.7M134.8M
Net Receivables965K10M488K720K12.8M13.4M
Common Stock Shares Outstanding1.4M1.7M2.0M2.9M3.8M3.1M
Capital Surpluse316.3M331.5M408.8M489.7M563.2M591.3M
Total Liab96.9M105.7M120.3M177.7M140.9M129.6M
Total Current Assets193.7M105.6M161.8M199.1M136.4M147.2M
Intangible Assets1.4M1.4M2.0M1.3M400K380K
Property Plant Equipment39.6M41.5M25.2M20.2M23.2M25.0M
Property Plant And Equipment Net39.6M41.5M29.3M23.2M14.6M27.9M
Current Deferred Revenue16.5M30.2M21.2M46.2M12.0M22.1M
Net Debt(180.9M)(79.3M)(134.6M)(162.5M)(85.4M)(89.7M)
Non Current Assets Total41.6M44.6M49.7M39.1M23.4M36.1M
Non Currrent Assets Other558K1.7M4.6M9.8M225K213.8K
Liabilities And Stockholders Equity235.2M150.2M211.5M238.2M159.8M189.5M
Non Current Liabilities Total70.0M62.9M84.4M118.1M90.9M94.4M
Other Current Assets2.3M5.8M17.6M8.8M6.9M8.5M
Other Stockholder Equity315.4M330.5M407.8M488.7M508.5M345.3M
Net Invested Capital138.3M44.4M93.6M82.7M41.3M65.0M
Property Plant And Equipment Gross39.6M41.5M53.2M54.3M40.1M40.5M
Net Working Capital166.7M62.7M125.8M139.4M86.4M115.9M
Short Term Debt6.8M3.9M3.6M1.7M23.5M24.7M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Precision BioSciences is a strong investment it is important to analyze Precision BioSciences' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Precision BioSciences' future performance. For an informed investment choice regarding Precision Stock, refer to the following important reports:
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Precision BioSciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
For more information on how to buy Precision Stock please use our How to buy in Precision Stock guide.
You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Precision BioSciences. If investors know Precision will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Precision BioSciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
0.4
Revenue Per Share
12.872
Quarterly Revenue Growth
(0.96)
Return On Assets
(0.06)
Return On Equity
0.2444
The market value of Precision BioSciences is measured differently than its book value, which is the value of Precision that is recorded on the company's balance sheet. Investors also form their own opinion of Precision BioSciences' value that differs from its market value or its book value, called intrinsic value, which is Precision BioSciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Precision BioSciences' market value can be influenced by many factors that don't directly affect Precision BioSciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Precision BioSciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Precision BioSciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Precision BioSciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.